iCAD Receives FDA Approval for FujiFilm Aspire HD Digital Mammography System

June 24, 2013 — iCAD, Inc. announced approval by the U.S. Food and Drug Administration (FDA) for use of the company’s SecondLook mammography computer-aided detection (CAD), on the next generation PowerLook Advanced Mammography Platform (AMP), for FujiFilm’s Aspire HD Full-Field Digital Mammography System.

PowerLook AMP provides radiologists with the ability to customize their CAD solution to meet the needs of their individual work environment. The technology expands on iCAD’s SecondLook Digital algorithm and is the CAD platform upon which all future breast imaging CAD offerings from iCAD will be built. SecondLook’s CAD metrics offer industry-leading tissue and lesion characteristics to support the breast imager’s workflow. In addition, PowerLook AMP is the first product of its kind to integrate M?takina’s Volpara Volumetric Breast Density assessment.

iCAD’s PowerLook AMP also provides the most powerful flexible digital imaging and communications in medicine (DICOM) connectivity solution, enabling universal compatibility with leading picture archive communications systems (PACS) and review workstations.

For more information: www.icadmed.com